BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35456509)

  • 1. Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs.
    Fagone P; Mangano K; Martino G; Quattropani MC; Pennisi M; Bella R; Fisicaro F; Nicoletti F; Petralia MC
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.
    Pang X; Zhao Y; Wang J; Zhou Q; Xu L; Kang D; Liu AL; Du GH
    Biomed Res Int; 2017; 2017():9084507. PubMed ID: 29359159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding the Role of Astrocytes in the Entorhinal Cortex in Alzheimer's Disease Using High-Dimensional Single-Nucleus RNA Sequencing Data and Next-Generation Knowledge Discovery Methodologies: Focus on Drugs and Natural Product Remedies for Dementia.
    Pushparaj PN; Kalamegam G; Wali Sait KH; Rasool M
    Front Pharmacol; 2021; 12():720170. PubMed ID: 35295737
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.
    Olajide OJ; Suvanto ME; Chapman CA
    Biol Open; 2021 Jan; 10(1):. PubMed ID: 33495355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.
    Li H; Zou L; Shi J; Han X
    Hereditas; 2021 Jul; 158(1):25. PubMed ID: 34243818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC
    Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic and Transcriptomic Analyses Reveal Pathological Changes in the Entorhinal Cortex Region that Correlate Well with Dysregulation of Ion Transport in Patients with Alzheimer's Disease.
    Jia Y; Wang X; Chen Y; Qiu W; Ge W; Ma C
    Mol Neurobiol; 2021 Aug; 58(8):4007-4027. PubMed ID: 33904022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.
    Chin J; Massaro CM; Palop JJ; Thwin MT; Yu GQ; Bien-Ly N; Bender A; Mucke L
    J Neurosci; 2007 Mar; 27(11):2727-33. PubMed ID: 17360894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Disease Mechanisms Linked to Alzheimer's Disease in the Entorhinal Cortex.
    Bottero V; Powers D; Yalamanchi A; Quinn JP; Potashkin JA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F; Kobayashi K; Nakamura I
    Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-Dependent Deregulation of Linear and Circular RNA Variants of HOMER1 in the Entorhinal Cortex of Alzheimer's Disease.
    Urdánoz-Casado A; Sánchez-Ruiz de Gordoa J; Robles M; Acha B; Roldan M; Zelaya MV; Blanco-Luquin I; Mendioroz M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated identification of key genes and pathways in Alzheimer's disease via comprehensive bioinformatical analyses.
    Yan T; Ding F; Zhao Y
    Hereditas; 2019; 156():25. PubMed ID: 31346329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entorhinal cortex dysfunction in Alzheimer's disease.
    Igarashi KM
    Trends Neurosci; 2023 Feb; 46(2):124-136. PubMed ID: 36513524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex.
    Yeung JHY; Walby JL; Palpagama TH; Turner C; Waldvogel HJ; Faull RLM; Kwakowsky A
    Brain Pathol; 2021 Nov; 31(6):e13005. PubMed ID: 34269494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.